Institut Gustave Roussy Hematologie

Villejuif 94805

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Hepatocellular, Lymphocytic Leukemia, Chronic

Studies at this site

• Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed
• A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC) — Completed